HARPAGOPHYTUM THC

Food supplement declared in France, declaration No 2021-7-173, decision dated 2 July 2021

HARPAGOPHYTUM THC (PARAGLYC) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand: PARAGLYC
Food business operator placing the product on the market: PARAGLYC
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: 3 gélules par jour
Directions for use: 3 gélules par jour au cours des repas
Not recommended for (according to the manufacturer): Enfants (moins de 12 ans), Femmes enceintes, Ulcère (estomac ou duodenum), Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims): Articulations

Declaration 316155, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

Plant	Part	Preparation	Per day
Harpagophytum procumbens	Racine	Extrait sec aqueux	1,740 mg

Additives

E464

List from the declaration, administrative decision dated 2 July 2021 (Compl'Alim, food supplement declarations (France)).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé en cas de calculs biliaires

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : PARAGLYC